Tianyi Wang – Trademark Portfolio
Entity Type: 01
Tianyi Wang owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as EMBOLOOM, FREEMYTH, RESHINEE, SPARKFLEX, and URBANGAZE. Of these, 7 are registered and 1 is pending. The portfolio spans 7 Nice Classification classes, led by Class 25 (Clothing) and Class 9 (Computers & Electronics). Headquartered in Xiamen, Fujian.
Room 402, No. 286,
Lujiang Road, Siming District
Xiamen, Fujian 361000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Tianyi Wang's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Tianyi Wang have?
Tianyi Wang has 9 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 pending, 1 cancelled.
What trademark classes does Tianyi Wang file in?
Tianyi Wang files trademarks across 7 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 9 (Computers & Electronics), Class 24 (Fabrics), Class 21 (Housewares), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.
What are Tianyi Wang's most well-known trademarks?
Tianyi Wang's registered trademark portfolio includes well-known marks such as EMBOLOOM, FREEMYTH, RESHINEE, SPARKFLEX, and URBANGAZE. These are among 7 currently registered trademarks in the portfolio.
What is Tianyi Wang's trademark registration success rate?
Tianyi Wang has a 88% trademark registration rate, with 7 out of 8 resolved applications resulting in successful registration. Currently, 1 application is pending review.